(NASDAQ: PRTC) Puretech Health's forecast annual revenue growth rate of 32.38% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.64%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.1%.
Puretech Health's revenue in 2024 is $15,618,000.On average, 2 Wall Street analysts forecast PRTC's revenue for 2024 to be $18,942,508,808, with the lowest PRTC revenue forecast at $5,069,906,769, and the highest PRTC revenue forecast at $32,815,110,847. On average, 2 Wall Street analysts forecast PRTC's revenue for 2025 to be $11,616,214,960, with the lowest PRTC revenue forecast at $2,757,806,429, and the highest PRTC revenue forecast at $20,474,623,491.
In 2026, PRTC is forecast to generate $11,254,078,762 in revenue, with the lowest revenue forecast at $2,033,534,034 and the highest revenue forecast at $20,474,623,491.